Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5551 | 1542 | 39.7 | 67% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MEASLES VIRUS | Author keyword | 87 | 36% | 13% | 193 |
2 | SSPE VIRUS | Author keyword | 26 | 100% | 1% | 11 |
3 | VIROL IMMUNOBIOL | Address | 7 | 13% | 3% | 49 |
4 | IMMUNOBIOL FONDAMENTALE CLIN | Address | 7 | 67% | 0% | 6 |
5 | MV RECEPTOR | Author keyword | 6 | 100% | 0% | 4 |
6 | VIRUS DIS VACCINE CONTROL | Address | 4 | 67% | 0% | 4 |
7 | VPV | Address | 4 | 75% | 0% | 3 |
8 | VIROL 3 | Address | 4 | 14% | 2% | 26 |
9 | SSPE | Author keyword | 4 | 20% | 1% | 16 |
10 | VIROL GENE THER Y TRACK | Address | 3 | 45% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEASLES VIRUS | 87 | 36% | 13% | 193 | Search MEASLES+VIRUS | Search MEASLES+VIRUS |
2 | SSPE VIRUS | 26 | 100% | 1% | 11 | Search SSPE+VIRUS | Search SSPE+VIRUS |
3 | MV RECEPTOR | 6 | 100% | 0% | 4 | Search MV+RECEPTOR | Search MV+RECEPTOR |
4 | SSPE | 4 | 20% | 1% | 16 | Search SSPE | Search SSPE |
5 | HOST DIRECTED | 3 | 60% | 0% | 3 | Search HOST+DIRECTED | Search HOST+DIRECTED |
6 | RECOMBINANT LIVE ATTENUATED VACCINE | 2 | 67% | 0% | 2 | Search RECOMBINANT+LIVE+ATTENUATED+VACCINE | Search RECOMBINANT+LIVE+ATTENUATED+VACCINE |
7 | RECOMBINANT MEASLES VIRUS | 2 | 67% | 0% | 2 | Search RECOMBINANT+MEASLES+VIRUS | Search RECOMBINANT+MEASLES+VIRUS |
8 | CD46 | 2 | 11% | 1% | 19 | Search CD46 | Search CD46 |
9 | PVRL4 | 2 | 50% | 0% | 3 | Search PVRL4 | Search PVRL4 |
10 | SUBACUTE SCLEROSING PANENCEPHALITIS | 2 | 10% | 1% | 18 | Search SUBACUTE+SCLEROSING+PANENCEPHALITIS | Search SUBACUTE+SCLEROSING+PANENCEPHALITIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EDMONSTON STRAIN | 85 | 92% | 2% | 34 |
2 | CD46 DOWN REGULATION | 67 | 87% | 2% | 33 |
3 | IMMUNOSUPPRESSION IN VITRO | 56 | 81% | 2% | 34 |
4 | SUBACUTE SCLEROSING PANENCEPHALITIS | 50 | 32% | 8% | 128 |
5 | BIASED HYPERMUTATION | 31 | 53% | 3% | 42 |
6 | HEMAGGLUTININ PROTEIN | 23 | 39% | 3% | 45 |
7 | SLAM TRANSGENIC MICE | 21 | 90% | 1% | 9 |
8 | UNCOMPLICATED DISEASE | 21 | 90% | 1% | 9 |
9 | WILD TYPE MEASLES | 21 | 90% | 1% | 9 |
10 | ATYPICAL MEASLES | 19 | 51% | 2% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Measles virus A pathogen, vaccine, and a vector | 2015 | 3 | 57 | 53% |
Measles Virus Receptors | 2009 | 39 | 84 | 76% |
Nectin 4 is the epithelial cell receptor for measles virus | 2012 | 19 | 71 | 68% |
Measles virus-induced suppression of immune responses | 2010 | 40 | 187 | 66% |
Measles virus, immune control, and persistence | 2012 | 18 | 163 | 64% |
Measles virus: cellular receptors, tropism and pathogenesis | 2006 | 87 | 133 | 59% |
Measles virus infection of the CNS: human disease, animal models, and approaches to therapy | 2010 | 29 | 125 | 71% |
Measles Virus-Induced Immunosuppression | 2009 | 32 | 141 | 67% |
Current Animal Models: Transgenic Animal Models for the Study of Measles Pathogenesis | 2009 | 23 | 54 | 81% |
Pathological consequences of systemic measles virus infection | 2015 | 1 | 88 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIROL IMMUNOBIOL | 7 | 13% | 3.2% | 49 |
2 | IMMUNOBIOL FONDAMENTALE CLIN | 7 | 67% | 0.4% | 6 |
3 | VIRUS DIS VACCINE CONTROL | 4 | 67% | 0.3% | 4 |
4 | VPV | 4 | 75% | 0.2% | 3 |
5 | VIROL 3 | 4 | 14% | 1.7% | 26 |
6 | VIROL GENE THER Y TRACK | 3 | 45% | 0.3% | 5 |
7 | TISSUE PATHOL S | 3 | 60% | 0.2% | 3 |
8 | INSERM U404 | 2 | 44% | 0.3% | 4 |
9 | EMORY DRUG DEV | 2 | 36% | 0.3% | 5 |
10 | IFR LAENNEC 62 | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000258426 | SUBACUTE SCLEROSING PANENCEPHALITIS//SSPE//SUBACUTE SCLEROSING PANENCEPHALITIS SSPE |
2 | 0.0000216522 | V PROTEIN//SENDAI VIRUS//PARAMYXOVIRUS |
3 | 0.0000215083 | CANINE DISTEMPER VIRUS//MORBILLIVIRUS//CANINE DISTEMPER |
4 | 0.0000182640 | MEASLES//MEASLES VACCINE//MEASLES ELIMINATION |
5 | 0.0000124296 | PESTE DES PETITS RUMINANTS//PESTE DES PETITS RUMINANTS VIRUS//PPRV |
6 | 0.0000105246 | PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP//MAYO CLIN VACCINE GRP |
7 | 0.0000104129 | CHANDIPURA VIRUS//VESICULAR STOMATITIS VIRUS//VESICULAR STOMATITIS |
8 | 0.0000074545 | CD59//CRRY//CD55 |
9 | 0.0000069038 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
10 | 0.0000063643 | MUMPS VIRUS//MUMPS//MUMPS VACCINE |